Three mule deer wandered up to a brand-new bridge near Grass Lake, in the far north of California, and walked across it. The bridge was built just for them, and other animals, and a trail camera caught them taking advantage of it. Remarkably, the bridge was not even finished being built when they used it.…Continue reading The Kind of People Who Build Bridges for Animals
For years, the only way to fight against the weedkiller Roundup has been in a courtroom. Individuals who asserted that their lives had been forever altered by cancer from the weedkiller sued its maker, Bayer, which purchased the chemical’s original manufacturer, Monsanto, by the tens of thousands. At times, juries agreed with the plaintiffs and…Continue reading Kennedy Is in the Room. But Whose Science Is on the Table?
$53.5 billion. That is what twenty of the world’s largest grain, fertilizer, meat, and dairy companies paid their shareholders over 2021 and 2022. The United Nations estimates that it would cost about $51.5 billion to feed the 230 million most desperate, hungry people on earth. So a single slice of the food industry handed out…Continue reading $53.5 Billion: A Food System That Feeds Its Investors
In America, infants are dying at a rate of around 1,300 to 4,500 per year, depending on the reporting source. Lives ended suddenly, unexplained, with the greater medical system appearing to be okay with it, as evidenced by their lack of deeper investigation into the ‘syndrome.’ Sudden Infant Death Syndrome (SIDS) has long haunted parents…Continue reading The Evolving Lens on SIDS: From Mystery to Focus on CDC’s Schedule
Make no mistake. The skies above us are no longer guaranteed to be blue and soothing. They have and will continue to become the battlefield of the future. When the so-called “contrails” behind jets are finally openly discussed as more than mere condensation—indeed, as sulfur dioxide being injected into the stratosphere—we must all open our…Continue reading Geoengineering: Above Our Heads, Against Our Will
From 2010 to 2024, data on the drug gabapentin show something deeply telling about our medical‑industrial complex. Specifically, a study published September 30, 2025, in Annals of Internal Medicine reveals that prescriptions of the drug (a GABA-analog drug approved for partial seizures and postherpetic neuralgia) exploded, going from around 24 million prescriptions in 2010 to…Continue reading Off Label, On Agenda: Gabapentin’s Rise and the Debauchery Behind It
Without question, the COVID-19 pandemic introduced not only a novel virus of suspicious origins but also a unique and tyrannical response riddled with experimental mRNA gene-damaging jabs—touted as vaccines to save the world—deployed to the masses using guilt, coercion, mandates, and emergency use authorization. Now, years later, an ever-growing group of medical professionals, scientists, and…Continue reading Informed Dissent: Exposing the Bioengineering of the Human Future
For decades, blood pressure guidelines in the United States have been frequently revised. Each modification has subtly redefined what constitutes hypertension, which, in the United States, is the No. 1 risk factor for heart disease and stroke. As expected, these changes are often presented as evidence-based refinements. But, are they? The most recent revision by…Continue reading The Pharmaceutical Redefinition of Blood Pressure